Structure Therapeutics, Inc. (GPCR)
66.55
-0.92
(-1.36%)
USD |
NASDAQ |
Feb 20, 16:00
66.56
+0.01
(+0.02%)
After-Hours: 20:00
Structure Therapeutics EPS Diluted (Quarterly) : -1.125 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Novo Nordisk A/S | 0.9419 |
| Pfizer Inc. | -0.2898 |
| Viking Therapeutics, Inc. | -1.383 |
| Dyne Therapeutics, Inc. | -0.7619 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -65.80M |
| Total Expenses (Quarterly) | 65.80M |
| Enterprise Value | 3.909B |
| Earnings Yield | -5.49% |
| Normalized Earnings Yield | -5.488 |